{"id":"W4296010496","doi":"10.1016/j.annonc.2022.07.857","title":"731MO A phase I trial of the bifunctional EGFR/TGFβ fusion protein BCA101 alone and in combination with pembrolizumab in patients with advanced solid tumors","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Tolerability; Internal medicine; Rash; Gastroenterology; Phases of clinical research; Expanded access; Oncology; Refractory (planetary science); Surgery; Adverse effect; Cancer; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055282,0.001104531,0.001366327,0.0003998335,0.0004938846,0.00110504,0.0005567629,0.0009845997,0.005343651],"category_scores_gemma":[0.000250419,0.0003972377,0.0009908114,0.0003784542,0.0006042105,0.0005677455,0.0002472923,0.003164971,0.00135224],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009840961,"about_ca_system_score_gemma":0.001494015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002555007,"about_ca_topic_score_gemma":0.007103084,"domain_scores_codex":[0.9997922,0.00005653971,0.000006757738,0.00003642467,0.00002427762,0.0000838108],"domain_scores_gemma":[0.999791,0.0000215661,0.00002033838,0.00001367255,0.00001587675,0.000137631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5080993,0.06813236,0.006066397,0.001247568,0.002646592,0.0004646134,0.0002795951,0.003513866,0.1864368,0.0009676295,0.01561277,0.2065325],"study_design_scores_gemma":[0.454214,0.4885424,0.02118295,0.00008885676,0.001094045,0.0005191864,0.0001580951,0.002770175,0.01820292,0.0003446524,0.01282482,0.00005792274],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862245,0.004024532,0.0004031479,0.001039536,0.0004438245,0.001555691,0.001296863,0.0001811655,0.004830753],"genre_scores_gemma":[0.9849949,0.002926061,0.001269837,0.001000647,0.0001633528,0.001270589,0.002503431,0.00003540598,0.005835662],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005343651,"threshold_uncertainty_score":0.01787627,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02320620779014601,"score_gpt":0.3092899193212572,"score_spread":0.2860837115311112,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}